Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
Stopped Study stopped 12/2010 due to poor enrollment. Only 15 of 60 needed enrolled.
Conditions
- Acquired Immune Deficiency Syndrome
Interventions
- DRUG: Lopinavir 400 mg/ritonavir 100 mg
- DRUG: Efavirenz
Sponsor
Rush University Medical Center
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]